Tech Company Financing Transactions
Corthera Funding Round
Corthera, based in San Mateo, received investment capital from Domain Associates, Kleiner Perkins Caufield & Byers and private investors.
Transaction Overview
Company Name
Announced On
12/31/2008
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Domain Associates (Dennis Podlesak)
Kleiner Perkins Caufield & Byers (Risa Stack)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
FinTech
Mailing Address
1660 S. Amphlett Blvd. 200
San Mateo, CA 94402
USA
San Mateo, CA 94402
USA
Phone
Website
Email Address
Overview
Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stan Abel
Chief Medical Officer
Sam Teichman
Chief Operating Officer
Rick Orr
Founder
Dennis Stewart
Vice President
Ernst Rinderknecht
Vice President
Elaine Unemori
Browse more venture capital transactions:
Prev: 12/31/2008: LOC-AID Technologies venture capital transaction
Next: 12/31/2008: Upperbeyond venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs